While COVID-19 made and continues to make the headlines, Indiana’s life sciences industry not only combatted the pandemic with testing, treatments, clinical trials, and vaccine manufacturing, but also remained committed to delivering medical breakthroughs in other areas. Indiana life sciences start-ups garnered a record high level of investment with more than $262 million going to 44 companies. That’s nearly$100 million more than 2019’s milestone of $171 million.
BioCrossroads advances Indiana’s signature strengths in the life sciences by connecting with corporate, academic and philanthropic partners; facilitating investments in promising start ups; building new enterprises; and educating through conferences, reports and market development knowledge.
NEWSLETTER SIGN UP
1210 Waterway Boulevard,
Indianapolis, IN 46202